Subscribe Now Subscribe Today
Research Article
 

Screening for Anti-angiogenic Activity in Shiitake Mushroom (Lentinus edodes Berk) Extracts



Custer C. Deocaris, Ma. Consolacion P. de Castro, Angel T. Oabel, Elisa L. Co and Elmer-Rico E. Mojica
 
Facebook Twitter Digg Reddit Linkedin StumbleUpon E-mail
ABSTRACT

The formation of new blood vessel from pre-existing vessels or angiogenesis is an important phenomenon in the pathology of solid tumor growth and metastasis. We found that chloroform extracts from Lentinus edodes (Berk.) Sing., an edible mushroom reported to demonstrate anti-tumor and immunomodulatory activities inhibited heparin-induced angiogenesis on chick chorioallantoic membrane. Methanol and hexane fractions appeared to have no anti-angiogenic activity. This study holds promise for the potential use of this mushroom as a dietary supplement for the management of various angiogenic-related diseases, especially cancer.

Services
Related Articles in ASCI
Similar Articles in this Journal
Search in Google Scholar
View Citation
Report Citation

 
  How to cite this article:

Custer C. Deocaris, Ma. Consolacion P. de Castro, Angel T. Oabel, Elisa L. Co and Elmer-Rico E. Mojica, 2005. Screening for Anti-angiogenic Activity in Shiitake Mushroom (Lentinus edodes Berk) Extracts. Journal of Medical Sciences, 5: 43-46.

DOI: 10.3923/jms.2005.43.46

URL: https://scialert.net/abstract/?doi=jms.2005.43.46

INTRODUCTION

Cancer cells, like normal cells, need a sufficient supply of nutrients and a mechanism for the removal of toxins. To fill this need, as tumor cells proliferate, they secrete substances that promote angiogenesis, or the growth of tiny blood vessels from pre-existing ones. Because these capillaries adequately feed and oxygenate the tumor bed, malignant cells present are stimulated to grow, penetrate into the lymphatic and blood vessels, circulate into the bloodstream, invade nearby tissue and finally spread to other parts of the body or metastasize. Dr. Judah Folkman in 1971 first proposed the idea that cancer growth can be controlled through the process of angiogenesis[1-3]. Isolation of natural substances that inhibit tumor-induced angiogenesis has been pursued. Among these potential drugs are angiostatin[4,5] and endostatin[6], both of which have successfully blocked angiogenesis and metastatic growth in mice and are presently undergoing phase-3 clinical trials[7].

Dietary approaches in cancer management is also gaining popularity as new in vitro and in vivo research results indicate that some of these food supplements do indeed show anti-cancer activities. Natural products capable of suppressing angiogenesis were reported in some medicinal supplements including epigallo catechin-O-gallate (EGCG) in Camelia sinensis (green tea)[8], genistein in Glycine max (soya beans)[9], diallyl sulfide in Alium sativum (garlic)[10], ginsenoside from Panax ginseng roots (ginseng)[11] and aminosterols and matrix metalloproteinase-inhibitors from shark cartilage[12].

Shiitake mushroom, Lentinus edodes (Berk), is a mushroom used commonly in Japanese and Chinese cuisine. KS-2 and a polysaccharide fraction from its adult fruiting bodies possesses anti-tumor activity against mouse implanted S-180 tumors and human hepatoma SMMC-7721 cells in vitro[13-18]. The bioactive polysaccharide fraction is believed to consist mainly of sulfated alpha (1→3)-D-glucan, a sulfated glycan derivative from the Shiitake mushroom, based on cytotoxicity assays with four tumor cell lines. From this experiment, human MCF-7 breast carcinoma cells was most responsive[19].

Another popular anti-carcinogenic agent from the Shiitake mushroom is lentinan, an immunopotentiator of T-cell and macrophage-mediated immunity[20]. Lentinan was able to suppress growth of human colon carcinoma cells in nude mice[21]. Clinical trials patients with gastric cancers reported significant improvements in survival rates possibly through improvement in immune functions. Complementarily, intake of lentinan has also helped AIDS-infected individuals experience a improved immunity against opportunistic infections[22]. With the outpouring of anti-cancer/carcinogenic properties attributed to intake of natural products from the Shiitake mushroom, it is of interest for this study to demonstrate anti-angiogenic properties that would highlight the importance of dietary interventions as adjunct to long-term cancer management.

MATERIALS AND METHODS

Solvent extraction: Initial methanolic crude extracts were obtained from dried fruiting bodies of shitake mushroom Lentinus edodes (Berk) (200 g) soaked in 1.5 L of methanol for three days. The extract was then subjected to solvent extractions: first, with hexane and followed by chloroform. Extraction with these solvents was done twice and both fractions were collected. Excess solvents were removed by rotary evaporation at 40°C under vacuum.

Chorioallantoic membrane (cam)assay: Two doses of the shitake mushroom extracts were used, 500 and 100 μg/egg. An angiogenic-inducer, heparin (10 μg/egg)[23] and an angiogenic-inhibitor, spironolactone (200 μg/egg)[24] were used as controls. These test substances were mixed together with 40% gelatin. After solidification, the gel sponge (total volume of 100 μL, diameter of 0.5 cm) was aseptically placed onto the CAM of ten-day old duck Anas luzonica eggs. The eggs were sealed with paraffin and incubated for 3 days at 37°C[25]. Examination of the blood vessels on the chorioallantoic membrane was done for angiogenetic inhibition.

RESULTS AND DISCUSSION

The angiogenic effect of the different solvent fractions of Shiitake mushroom Lentinus edodes (Berk) extract was determined using the chorioallantoic membrane (CAM) assay with duck Anas luzonica (Fraser 1839) embryo. CAM assay is considered as one of the most common methods for screening angiogenic substances[25, 26]. Some of the recent angiogenic inhibitors screened using CAM assay include zoledronic acid[27], ,anginex[28], 2-nitroimidazole KIN-841[29] and endorepellin[30].

Results from the different treatments showed that only high dosage chloroform fraction showed angiogenic inhibition. In addition, natural products that fractionated in the chloroform solvent were able to overcome angiogenic-induction with heparin. There is lesser branching of blood vessels on the chorioallantoic membrane similar to anti-angiogenesis activity of spironolactone with and without heparin on the duck CAM. A dose response was evident as the lower dosage of the chloroform fraction displayed lesser degree of angiogenic inhibition.

The activity of the chloroform extract could be attributed to lentinan because of its semi-polar nature[13]. In comparison, methanolic and hexane fractions contain the polar and non-polar components, respectively. Other substances that fractionated in chloroform may be responsible for the anti-angiogenic activity. A semi-polar compound distinct from lentinan was found to increase IL-1 production and apoptosis in the U-937 monocytic cell line[31]. Another candidate anti-angiogenic agent is lenthionine, an antibacterial and antifungal sulfur-containing compound, that can be extracted by chloroform[32]. Further validation of these isolated natural products from shiitake mushroom is highly warranted.

Chloroform fraction from shiitake mushroom Lentinus edodes (Berk) produces an anti-angiogenic effect on the chorioallantoic membrane of the duck Anas luzonica (Fraser, 1839) embryo in the presence or absence of an angiogenic-inducer, heparin. The other fractions, hexane and methanol fractions neither stimulated nor inhibited angiogenesis.

REFERENCES
1:  Folkman, J., 1971. Tumor angiogenesis: Therapeutic implications. N. Engl. J. Med., 285: 1182-1186.
CrossRef  |  PubMed  |  Direct Link  |  

2:  Folkman, J., 1974. Tumor angiogenesis. Adv. Cancer Res., 19: 221-258.

3:  Folkman, J., R. Langer, R.J. Linhardt, C. Haudenschild and S. Taylor, 1983. Angiogenesis inhibition and tumor regression caused by heparin or heparin fragment in the presence of cortisone. Science, 221: 719-725.

4:  Moses, M.A., J. Sudhalter and R. Langer, 1990. Identification of an inhibitor of neovascularization from cartilage. Science, 248: 1408-1410.

5:  O'Reilly, M.S., L. Holmgren, Y. Shing, C. Chen and R. Rosenthal et al., 1994. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell, 79: 315-328.
PubMed  |  

6:  O'Reilly, M.S., T. Boehm, Y. Shing, N. Fukai and G. Vasios et al., 1997. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell, 88: 277-285.
CrossRef  |  PubMed  |  Direct Link  |  

7:  Olson, K.A., J.W. Fett, T.C. French, M.E. Key and B.L. Vallee, 1995. Angiogenin antagonists prevent tumor growth in vivo. Proc. Natl. Acad Sci. USA., 92: 442-446.

8:  McCarty, M.F., 1998. Polyphenol-mediated inhibition of AP-1 transactivating activity may slow cancer growth by impeding angiogenesis and tumor invasiveness. Med. Hypothesis, 50: 511-514.

9:  Fotsis, T., M. Pepper, H. Adlercreutz, G. Fleischmann, T. Hase, R. Montesano and L. Schweigerer, 1993. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc. Natl. Acad. Sci. USA., 90: 2690-2694.
Direct Link  |  

10:  Shukla, Y., A. Arora and A. Singh, 2002. Antitumorigenic potential of diallyl sulfide in Ehrlich ascites tumor bearing mice. Biomed. Environ. Sci., 15: 41-47.

11:  Sato, K., M. Mochizuki, I. Saiki, Y.C. Yoo, K. Samukawa and I. Azuma, 1994. Inhibition of tumor angiogenesis and metastasis by a saponin of Panax ginseng, ginsenoside-Rb2. Biol. Pharm. Bull., 17: 635-639.

12:  Davis, P.F., Y. He, R.H. Furneaux, P.S. Johnston, B.M. Ruger and G.C. Slim, 1997. Inhibition of angiogenesis by oral ingestion of powdered shark cartilage in a rat model. Microvascular Res., 54: 178-182.

13:  Chihara, G., Y. Maeda, J. Hamuro, T. Sasakia and F. Fukuoka, 1969. Inhibition of mouse sarcoma 180 by polysaccharides from Lentinus edodes (Berk.) sing. Nature, 222: 687-688.
PubMed  |  Direct Link  |  

14:  Chihara, G., J. Hamuro, Y. Maeda, Y. Arai and F. Fukuoka, 1970. Fractionation and purification of the polysaccharides with marked antitumor activity, especially Lentinan from Lentinus edodes (Berk) Sing. (An edibole mushroom). Can. Res., 30: 2776-2781.
PubMed  |  Direct Link  |  

15:  Fujii, T., H. Maeda, F. Suzuki and N. Ishida, 1978. Isolation and characterization of a new antitumor polysaccharide, KS-2, extracted from culture mycelia of Lentinus edodes. J. Antibiot., 31: 1079-1090.

16:  Sugano, N., Y. Hibino, Y. Choji and H. Maeda, 1982. Anticarcinogenic actions of water-soluble and alcohol-insoluble fractions from culture medium of Lentinus edodes mycelia. Cancer Lett., 17: 109-114.

17:  Sugano, N., Y. Choji, Y. Hibino, S. Yasumura and H. Maeda, 1985. Anticarcinogenic action of an alcohol-insoluble fraction (LAP1) from culture medium of Lentinus edodes mycelia. Cancer Lett., 27: 1-6.

18:  Jiang, S.M., Z.M. Xiao and Z.H. Xu, 1999. Inhibitory activity of polysaccharide extracts from three kinds of edible fungi on proliferation of human hepatoma SMMC-7721 cell and mouse implanted S180 tumor. World J. Gastroenterol., 5: 404-407.
PubMed  |  

19:  Zhang, P. and P.C. Cheung, 2002. Evaluation of sulfated Lentinus edodes α-(/3)-D-glucan as a potential antitumor agent. Biosci. Biotechnol. Biochem., 66: 1052-1056.

20:  Ng, M.L. and A.T. Yap, 2002. Inhibition of human colon carcinoma development by lentinan from shiitake mushrooms (Lentinus edodes). J. Altern. Complement Med., 8: 581-589.

21:  Klauber, N., F. Bowne, B. Anand-Apte and R.J. D`Amato, 1996. New activity of spironolactone inhibition of angiogenesis in vitro and in vivo. Circulation, 94: 2566-2571.

22:  Ribatti, D., B. Nico, A. Vacca, L. Roncali and M. Presta, 1999. Endogenous and exogenous wound fibroblast growth factor-2 modulate wound healing in the chick embryo chorioallantoic membrane. Angiogenesis, 3: 89-95.

23:  Wood, J., K. Bonjean, S. Ruetz, A. Bellahcene and L. Devy et al., 2002. Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J. Pharmacol. Exp. Ther., 302: 1055-1061.

24:  Van der Schaft, D.W.J., R.P.M. Dings, Q.G. de Lussanet, L.I. van Eijk and A.W. Nap et al., 2002. The designer anti-angiogenic peptide anginex targets tumor endothelial cells and inhibits tumor growth in animal models. FASEB J., 16: 1991-1993.
CrossRef  |  Direct Link  |  

25:  Shimamura, M., H. Nagasawa, H. Ashino, Y. Yamamoto and T. Hazato et al., 2003. A novel hypoxia-dependent 2-nitroimidazole KIN-841 inhibits tumour-specific angiogenesis by blocking production of angiogenic factors. Br. J. Cancer, 88: 307-313.
CrossRef  |  Direct Link  |  

26:  Mongiat, M, S.M. Sweeney, J.D. San Antonio, J. Fu and R.V. Iozzo, 2003. Endorepellin, a novel inhibitor of angiogenesis derived from the C terminus of perlecan. J. Biol. Chem., 278: 4238-4249.
CrossRef  |  PubMed  |  Direct Link  |  

27:  Sia, G.M. and J.K. Candlish, 1999. Effects of shiitake (Lentinus edodes) extract on human neutrophils and the U937 monocytic cell line. Phytother. Res., 13: 133-137.
CrossRef  |  Direct Link  |  

28:  Hatvani, N., 2001. Antibacterial effect of the culture fluid of Lentinus edodes mycelium grown in submerged liquid culture. Int. J. Antimicrob. Agents, 17: 71-74.
CrossRef  |  Direct Link  |  

29:  Hamuro, J. and G. Chihara, 1984. Lentinan, A T-cell Oriented Immunopotentiator. Chapter 19, Marcel Dekker, Inc., New York, pp: 409-436.

30:  Aoki, T., 1984. Lentinan in Modulation Agents and their Mechanism. Marcel Dekker, Inc., New York, pp: 63-77.

31:  Riordan, M.H., X. Meng and H.D. Riordan, 2000. Anti-angiogenic, anti-tumor and immunostimulatory effects of a non-toxic plant extract (PGM). http://www.aidanproducts.com/articles/pgm.pdf.

32:  Daniel, T., 2000. Angiogenesis assays available from the vascular biology group at vanderbilt. http://bret.mc.vanderbilt.edu/vbc/html/2Assays.htm.

©  2021 Science Alert. All Rights Reserved